SUMMARY. We have evaluated a semi-quantitative dry immunochemical screening method (Micral-Test) for the detection of low concentrations of albumin in urine.
predict a discriminating urine albumin concentration > 30 mg/L by the in house method.
The Micral-Test is suitable for use by non-laboratory personnel and is capable of producing analytically acceptable results for use in diabetes clinics and by general practitioners.
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The concentration of albumin in the urine (microalbuminuria) is important in the management of diabetes mellitus as a predictor of later proteinuria indicating advancing diabetic nephropathy. ' The contention that early treatment with blood pressure lowering agents and improved glycaemic control may reduce albumin loss has resulted in increasing use of the measurement of urinary albumin in the management of diabetic patients.v" A number of radioimmunoassay and immunoturbidimetric methods have been described for the laboratory measurement of low concentrations of urinary albumin." In addition a number of screening procedures have been developed (Albuscreen, Cambridge Life Sciences; Microbumin Test, Miles Laboratories; and more recently a dry immunochemical method, MicralTest, Boehringer Mannheim) and promoted for use by laboratory, medical and nursing staff.
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In this paper we report the analytical performance of the Micral-Test compared with a laboratory immunoturbidimetric method.
METHODS
Micral-Test (Boehringer Mannheim, Marburg, Germany) has been designed to detect concentrations of urinary albumin in the range 0-100 mg/L by a dry immunochemical method. The test strip is dipped into the urine sample to a specified depth, removed, and then allowed to incubate at room temperature for 5 min. After moving across a buffer pad (pH = 7' 0) the urinary albumin combines with a soluble antialbumingalactosidase conjugate. The albumin-antibodygalactosidase complex and excess .conjugate is eluted onwards to an area containing immobilized albumin where excess conjugate is captured. The albumin-antibody-galactosidase complex then moves onto the substrate pad where the galactosidase reacts with chlorphenolredgalactoside causing a colour change from yellow to red. After incubation at room temperature for 5 min the strip colour pad is compared to colour blocks provided on the product container. Blocks for 0, 10, 20, 50 and 100 mg/L provide a semi-quantitative estimation of albumin concentration.
A test urine was prepared by adding human albumin (20 mg/L) to a patient urine with pH 5 '4, osmolality 265 mosmollkg and containing urea (86 mmollL), creatinine (1. 8 mmollL), sodium (65 mmollL) and potassium (16' 8 mmoIlL). This urine was aliquoted and stored at -9°C for use in all strip evaluations.
Colour development with time Following the dipping of four Micral-Test strips into the test urine, the colour development was read at 1 min intervals for 10 min after 3 min initial delay.
Urine composition
The composition of the test urine was changed to test separately the effect of increased concentrations of sodium, potassium, creatinine, urea (500, 500, 50, 1000 mmol/L final concentration, respectively) and pH (8' 9 and 3· 0) on the results obtained using the Micral-Test. Two strips were used in each test urine.
Depth of dipping
Results obtained by dipping a Micral-Test strip into the test urine to the correct position (to the bottom of the blue zone) were compared to results obtained by dipping three strips to half and three quarters up the blotter pad, and to the top of the blue zone.
Temperature Two Micral-Test strips stored at ODC, 21°C, 27°C, 30°C, 36 DC and 42°C were immediately dipped into the test urine (as described by the manufacturer) and allowed to incubate at room temperature for the recommended time. Test strips stored at the above temperatures were also dipped into the test urine and then incubated at the storage temperature.
Storage Micral-Test strips were stored with a desiccant at room temperature, both in the dark (eight strips) and in the light (eight strips), for up to 60 days. Strips were also stored in the dark in conditions of high humidity (in a sealed container, above water) for up to 22 h.
Micral-Test recovery
Human albumin was added to a urine with undetectable albumin levelsby immunoturbidimetry to give final concentrations of 20,50, and 100 mg/L corresponding to the colour pads for Micral-Test. The albumin concentrations of these urines were confirmed by immunoturbidimetry and then assayed using a singleMicral-Test strip at each concentration.
Laboratory immunoturbidimetric albumin measurement compared to Micral-Test strip Three laboratory workers (A, B and C) used Micral-Test strips to measure the albumin concentration in 184 diabetic urine samples previously analysed using an immunoturbidimetric method (Cambridge Life Sciences, Cambridge, UK) on a Hitachi 704 analyser (Boehringer Mannheim, Germany)." When this assay was established in our laboratory" its accuracy was confirmed using standards prepared by adding human albumin to urine to give final concentrations of 0,25,50, 100,200 and 400 mg/L, In routine use this assay gave within-batch coefficients of variation of 1· 5OJo at an albumin concentration of 20 mg/L and 1. 1% at 78 mg/L.
RESULTS

Colour development
After Micral-Test strip was dipped into the sample the intensity of colour development continued to increase during the 10 min observation period. Results for one strip are shown in Fig. 1 . Similar results were obtained for all strips tested.
Urine composition Increased concentrations of sodium and potassium had no effect on the level of albumin measured by Micral-Test (20 mg/L) while changes of osmolality (by increasing urea and creatinine concentration) and of pH caused a slight decrease in the measured concentration ( < 20, but> 10 mg/L).
Depth of dipping
Increasing or decreasing the depth of dipping of Micral-Test strip into the sample, respectively, substantially increased or decreased the albumin concentration measured (Table 1) . Immunoturbidimetric assay recovery Assayresponsewaslinearup to 400 mglL with recoveries of 100, 100, 100, lOS, 100 and 1OOOJo at 0,25, 50, 100,200, and 400 mg/L albumin, respectively.
Micra1-Test recovery
The colours developed by Micral-Test strip with urine albumin concentrations of0, 20, 50, 100rng/L matched the appropriate colour on the test pads.
If urine albumin screening methods are to be used in outpatient clinics they must be simple and quick to use, robust, and be able to detect urine albumin concentration with good specificity and sensitivity compared to the radioimmunoassays and immunoturbidimetricmethods currentlyused by laboratories. In the present study results produced by the Micral-Test method were not influenced by variables such as storage conditions, temperature of reaction and urine composition. However, the most critical variables for strip performance were those most strongly influenced by the operator. In particular. care needs to be taken regarding the depth of dipping the strip into the sample and the timing of reading. The colour intensity increases Table 2 , and the number of true and false positive and negative results for each operator using Micral-Test are shown in Table 3 Storage Storing Micral-Test strips in conditions of high humidity (in the dark) had no effect for up to 6 h, but by 22 h the strip response had fallen markedly (three strips tested). There was no change in Micral-Test strip response to albumin after strip storage at room temperature, both in the dark (four strips tested) and light (four strips tested) for 15 days. However, after 60 days the apparent albumin results obtained decreased markedly for strips stored both in the dark and light.
heating at 42°C an increase (> 20, but < 50 rng/L) in the apparent albumin measured.
Incubation at O°C « 10 mg/L), 36°C and 42°C (both > 20, but < 50 mg/L) caused changes in the amount of apparent albumin measured while at 21°C, 27°C and 30°C there was no change. rapidly after the recommended reading time such that a delay of 1 min in reading the albumin concentration will cause a positive error of approximately 40OJo. In addition all users in the present study noted that care had to be taken in reading the 50 mg/L colour pad (brick red) and the 100 mg/L colour pad (wine red) because of colour similarity. We believe that all users need to be educated in the critical aspects of using this technology, as is the case for all rapid diagnostic techniques. When compared to the laboratory measurement of urine albumin a Micral-Test result of~20 mg/L showed good specificity (that is few false positives), but poor sensitivity (fairly high number of false negatives) when the discriminating albumin concentration was 20 mg/L by immunoturbidimetry. However, by using a Micral-Test result 20 mg/L to predict a discriminating albumin concentration of 30 mg/L (which we believe would be acceptable clinically as a screen) there was a marked improvement in sensitivity with little change in specificity. Similarly, the negative predictive value of Micral-Test improved at an albumin cut off point of 30 mg/L.
The performance of the Micral-Test strip reported in this study compares well with the 96OJo sensitivity and 88OJo specificity at 30 mg/L, reported for the Albuscreen latex particle immunoassay screen 7 and with the 97OJo specificity and 93OJo sensitivity at a discriminating albumin concentration of 40 mg/L reported for MicroBumintest tablets." With Micro-Bumintest the predictive values of a positive test were 89OJo and 95OJo at cut off values of 40 mg/L and 30 mg/L, respectively," compared to 95OJo for Micral-Test at~20 mg/L to predict a cut off of 30 rng/L found in the present study.
A more recent publication has reported numerous false positives with Micro-Bumintest which were unrelated to pH or the presence of blood, both of which have been reported to cause interference in this test. 9 Such results raise the possibility of reaction with non-protein components of the urine, and indeed a study by Jung et al. 1O reported that creatinine, uric acid, urea and sodium chloride interfere with the colorimetry of urinary albumin with bromphenol blue, the dye used in MicroBumintest test tablets. Antibody-based screening methods such as Micral-Test and Albuscreen should confer an advantage in specificity for albumin.
Large numbers of diabetic patients are at risk of substantial morbidity and mortality associated with diabetic nephropathy.l-? With mounting evidence that early detection of increased urinary albumin and clinical intervention may prevent progression to advanced renal disease3.4.14.15 the measurement of microalbuminuria has become an essential part of the biochemical assessment of these patients. In an earlier study!' we showed that if a random urine albumin concentration is normal, then the majority of samples over a subsequent 5 year period were also normal, and suggested that a yearly urine albumin test should be carried out in those patients whose initial test is within the normal range. It would seem, from the present study, that Micral-Test is adequate for this screening and could be used by general practitioners, nurses, or small laboratories without the resources for establishing radioimmunoassays or immunoturbidimetric assays. Those patients with a result outside the normal range could receive further testing either with Micral-Test, or preferably with a laboratory immunoassay to establish the severity of renal disease.
In support of assessing the urinary albumin concentration from a single void urine sample we have noted a good correlation between the first albumin/creatinine ratio determination and the mean of subsequent samples;'! and between the albumin/creatinine ratio and timed urine collections. 12 ,13 In addition it has been observed that correction for the urine creatinine concentration adds little to the correlation, only a small improvement in sensitivity.'! Thus the most appropriate way to use albumin screening methods such as Micral-Test would seem to be with random urine samples.
In summary the Micral-Test appears to provide a robust, sensitive and specific test for clinic screening for increased urinary albumin.
